Upcoming Events

At the end of the session participants will be able to recognize the presentation of school refusal, and provide strategies to effectively work with schools to ensure that children and adolescents have the best opportunities to learn at school from pre-kindergarten through high school.

At the end of the session participants will be able to recognize the indications of pharmacological treatments of depression in children and adolescents, including the risk and benefits of common types of antidepressants that have indications for use in this population.

At the end of the session participants will be able to compare and contrast the simulants, non-stimulants, and novel therapies for ADHD, describing risks and benefits of each, along with relevant effective sizes for managing ADHD symptoms in youth.

At the end of the session participants will be able to discuss the various etiologies of trauma, and use and scoring of evidence-based screening scales and questionnaires to assess trauma.

At the end of the session participants will be able to recognize and describe the presentation of aggression in children and adolescents related to autism spectrum disorder, and provide pharmacological and non-pharmacological evidence-based strategies for addressing this form of aggression.